Motexafin lutetium
3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;lutetium(3+);diacetate;hydrate
Molecular Identity
Motexafin lutetium
3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;lutetium(3+);diacetate;hydrate
PubChem CID: 3081907
2D Structure
Properties
C52H74LuN5O15
Molecular Formula
1184.10
Molecular Weight
g/mol
1183.4589
Exact Mass
Da
246
TPSA
May have limited oral absorption
3
H-Bond Donors
20
H-Bond Acceptors
1900
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Motexafin lutetiumMotexafin lutetium hydrateLutetium texaphyrinFP-LP1Motexafin lutetium [USAN]Lu texaphyrinLu-TexPCI-01230A85BJ22L6156436-90-7NSC-695239NSC 695239UNII-0A85BJ22L6SCHEMBL1650511MOTEXAFIN LUTETIUM [MI]
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Motexafin lutetium
Loading drug network...